Furthermore, another study66 examined PTEN and PIK3CA mutations in 186 adenocarcinomas and 16 adenomas from the EPIC Norfolk study using DNA sequencing and assessed changes in PTEN expression through immunohistochemistry. This evidence concerns the gene PTEN and adenoma.